CA3242451A1 - An injectable pharmaceutical composition for the treatment of respiratory diseases in animals - Google Patents
An injectable pharmaceutical composition for the treatment of respiratory diseases in animalsInfo
- Publication number
- CA3242451A1 CA3242451A1 CA3242451A CA3242451A CA3242451A1 CA 3242451 A1 CA3242451 A1 CA 3242451A1 CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A CA3242451 A CA 3242451A CA 3242451 A1 CA3242451 A1 CA 3242451A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical composition
- injectable pharmaceutical
- animals
- treatment
- respiratory diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21217704 | 2021-12-24 | ||
| EP21217704.2 | 2021-12-24 | ||
| PCT/EP2022/087700 WO2023118557A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3242451A1 true CA3242451A1 (en) | 2023-06-29 |
Family
ID=79601675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3242451A Pending CA3242451A1 (en) | 2021-12-24 | 2022-12-23 | An injectable pharmaceutical composition for the treatment of respiratory diseases in animals |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057790A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4452226A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024544415A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118632684A (cg-RX-API-DMAC7.html) |
| AR (1) | AR128074A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022420882A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3242451A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024007862A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023118557A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| AR134777A1 (es) | 2023-12-21 | 2026-04-01 | Intervet Int Bv | Formas cristalinas de sales de (s)-n-(3-amino-1-(hidroxiamino)-3-metil-1-oxobutan-2-il)-4-((4-(((2-metoxietil)amino)metil)fenil)etinil)benzamida |
| CN122422289A (zh) | 2023-12-21 | 2026-07-17 | 英特维特国际股份有限公司 | (s)-n-(3-氨基-1-(羟基氨基)-3-甲基-1-氧代丁-2-基)-4-((4-(((2-甲氧基乙基)氨基)甲基)苯基)乙炔基)苯甲酰胺盐的结晶形式的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3740421A (en) | 1966-09-19 | 1973-06-19 | Basf Wyandotte Corp | Polyoxyethylene-polyoxypropylene aqueous gels |
| JP7082445B2 (ja) | 2016-12-23 | 2022-06-08 | インターベット インターナショナル ベー. フェー. | ウシ又はブタの呼吸器疾患を治療するための化合物 |
-
2022
- 2022-12-22 AR ARP220103558A patent/AR128074A1/es unknown
- 2022-12-23 MX MX2024007862A patent/MX2024007862A/es unknown
- 2022-12-23 CA CA3242451A patent/CA3242451A1/en active Pending
- 2022-12-23 US US18/721,947 patent/US20250057790A1/en active Pending
- 2022-12-23 AU AU2022420882A patent/AU2022420882A1/en active Pending
- 2022-12-23 CN CN202280085114.3A patent/CN118632684A/zh active Pending
- 2022-12-23 JP JP2024537407A patent/JP2024544415A/ja active Pending
- 2022-12-23 EP EP22844124.2A patent/EP4452226A1/en active Pending
- 2022-12-23 WO PCT/EP2022/087700 patent/WO2023118557A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023118557A1 (en) | 2023-06-29 |
| US20250057790A1 (en) | 2025-02-20 |
| AU2022420882A1 (en) | 2024-06-20 |
| MX2024007862A (es) | 2024-07-09 |
| JP2024544415A (ja) | 2024-11-29 |
| EP4452226A1 (en) | 2024-10-30 |
| AR128074A1 (es) | 2024-03-20 |
| CN118632684A (zh) | 2024-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024007862A (es) | Una composicion farmaceutica inyectable para el tratamiento de enfermedades respiratorias en animales. | |
| GEP20002298B (en) | Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment | |
| JP2007500697A5 (cg-RX-API-DMAC7.html) | ||
| BRPI0618374A2 (pt) | uso de um composto ou um derivado do mesmo farmaceuticamente aceitável, métodos para matar microorganismos clinicamente latentes em um mamìfero, para tratar ou prevenir uma infecção microbiana em um mamìfero, para esterilizar um objeto, para preservar um material inorgánico ou orgánico, para tratar uma doença, para reduzir a dose de agente antimicrobiano convencional requerida para tratar uma infecção microbiana e para tratar uma doença de protozoário em um mamìfero, produto combinado, formulação, uso de um produto combinado, composto, e, processo para a preparação do mesmo | |
| EP0820281B1 (en) | A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses | |
| RU2414902C1 (ru) | Бактерицидная композиция для профилактики и лечения инфекционных заболеваний копыт у животных | |
| SE9901573D0 (sv) | New compounds | |
| RU94008616A (ru) | 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций | |
| Adegbeye et al. | Potential of silver nanoparticles for veterinary applications in livestock performance and health | |
| RU2107502C1 (ru) | Ветеринарный препарат, обладающий широким спектром действия, - йод однохлористый | |
| JP2013539466A5 (cg-RX-API-DMAC7.html) | ||
| CA2386685A1 (en) | Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases | |
| CN114712355B (zh) | Rhps4在制备抑制金黄色葡萄球菌和铜绿假单胞菌药物中的应用 | |
| AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
| EP2250887B1 (en) | Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins | |
| KR100227125B1 (ko) | 미포자충감염을치료하기위한벤즈이미다졸구충제의용도 | |
| RU2203035C1 (ru) | Фармацевтическая композиция с дезинфицирующими, спороцидными и ранозаживляющими свойствами | |
| EP0992241A4 (en) | MEDICAL COMPOSITIONS AGAINST HELICOBACTER PYLORI | |
| AU4519189A (en) | Medicaments for the treatment of toxoplasmosis | |
| RU2083207C1 (ru) | Способ лечения экспериментального сапа у золотистых хомячков | |
| HUT62474A (en) | Process for producing veterinary composition with antiparasitic effect | |
| RU2005140156A (ru) | Применение аивлозина для лечения болезней, вызванных brachyspira pilosicoli или ornithobacterium rhinotracheale | |
| PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia | |
| RU1818095C (ru) | Препарат дл профилактики и лечени бронхопневмании сельскохоз йственных животных | |
| JP2002284604A (ja) | 抗菌防黴助剤 |